Cargando…

HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF Splicing

Hepatocellular carcinoma (HCC) is one of the most lethal human cancers. Hepatitis B virus (HBV) infection accounts for nearly 50% of HCC cases. Recent studies indicate that HBV infection induces resistance to sorafenib, the first-line systemic treatment for advanced HCC for more than a decade, from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lijuan, Lv, Zhao, Wang, Miao, Zhang, Dongyan, Liu, Dongying, Zhu, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967099/ https://www.ncbi.nlm.nih.gov/pubmed/36834680 http://dx.doi.org/10.3390/ijms24043263

Ejemplares similares

PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2021)

Pan-cancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors
por: Liu, Xiaowei, et al.
Publicado: (2022)

Splicing factor SRSF6 mediates pleural fibrosis
por: Liang, Li-Mei, et al.
Publicado: (2021)

SRSF1-mediated alternative splicing is required for spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023)

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
por: Gout, Stephanie, et al.
Publicado: (2012)

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

SRSF2 is required for mRNA splicing during spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023)

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
por: Li, Bowen, et al.
Publicado: (2021)

Splicing factor SRSF2-centric gene regulation
por: Li, Kun, et al.
Publicado: (2021)

Targeting Splicing Factor SRSF6 for Cancer Therapy
por: She, Wenting, et al.
Publicado: (2021)

SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing
por: Liu, Wenbo, et al.
Publicado: (2022)

The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1
por: Yao, Zhilu, et al.
Publicado: (2023)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

Splicing factor Srsf5 deletion disrupts alternative splicing and causes noncompaction of ventricular myocardium
por: Zhang, Xiaoli, et al.
Publicado: (2021)

Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1
por: Wang, Xin, et al.
Publicado: (2011)

PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3
por: Chen, Dawei, et al.
Publicado: (2021)

SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma
por: Wen, Chaowei, et al.
Publicado: (2022)

The Splicing Factor SRSF1 as a Marker for Endothelial Senescence
por: Blanco, Francisco Javier, et al.
Publicado: (2012)

Splicing factor SRSF6 promotes hyperplasia of sensitized skin
por: Jensen, Mads A., et al.
Publicado: (2014)

HIV-1 transcription is regulated by splicing factor SRSF1
por: Paz, Sean, et al.
Publicado: (2014)

SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF
por: Chen, Yinshuang, et al.
Publicado: (2022)

Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis
por: Pan, Liang, et al.
Publicado: (2021)

ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma
por: Cai, Mengxing, et al.
Publicado: (2023)

PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis
por: Liu, Xiaowei, et al.
Publicado: (2022)

AB068. The splicing factor SRSF1 expression in human bladder carcinoma cells
por: Wang, Ping, et al.
Publicado: (2016)

Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
por: Comiskey, Daniel F., et al.
Publicado: (2015)

Titin Circular RNAs Create a Back-Splice Motif Essential for SRSF10 Splicing
por: Tijsen, Anke J., et al.
Publicado: (2021)

NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer
por: Magallanes-Garza, Gerardo I., et al.
Publicado: (2022)

SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion
por: Moon, Heegyum, et al.
Publicado: (2017)

Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma
por: Liu, Man-ru, et al.
Publicado: (2023)

Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth
por: Chen, Yuhan, et al.
Publicado: (2018)

The translational landscape of the splicing factor SRSF1 and its role in mitosis
por: Maslon, Magdalena M, et al.
Publicado: (2014)

Recurrent SRSF2 mutations in MDS affect both splicing and NMD
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020)

Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors
por: Che, Yingying, et al.
Publicado: (2020)

Splicing factor SRSF1 is indispensable for regulatory T cell homeostasis and function
por: Katsuyama, Takayuki, et al.
Publicado: (2021)

SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018)

YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
por: Gao, Ruize, et al.
Publicado: (2021)

Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
por: Byun, Jun-Kyu, et al.
Publicado: (2022)

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
por: Li, Yan, et al.
Publicado: (2023)

Fe(3+)-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
por: Xiao, Youmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ak0qmtv4ubvbmtq0ff67c2fd18